Evidence map›Paper›PMID 31069715›Full record

ArticleBiological trace element research2020

The Effect of Boron-Containing Nano-Hydroxyapatite on Bone Cells.

Merve Gizer, Sevil Köse, Beren Karaosmanoglu, Ekim Z Taskiran, Aysel Berkkan, Muharrem Timuçin, Feza Korkusuz, Petek Korkusuz

Abstract read
PubMed Publisher
In one paragraph

Article in Biological trace element research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Merve GizerGraduate School of Science and Engineering, Department of Bioengineering, Hacettepe University, Ankara, Turkey.
Sevil KöseFaculty of Medicine, Department of Medical Biology, Atilim University, Ankara, Turkey.
Beren KaraosmanogluDepartment of Medical Genetics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Ekim Z TaskiranDepartment of Medical Genetics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Aysel BerkkanDepartment of Analytical Chemistry, Gazi University Faculty of Pharmacy, Ankara, Turkey.
Muharrem TimuçinDepartment of Metallurgical and Materials Engineering, Middle East Technical University Faculty of Engineering, Ankara, Turkey.
Feza KorkusuzDepartment of Sports Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Petek KorkusuzDepartment of Histology and Embryology, Hacettepe University Faculty of Medicine, 06100 Sihhiye, Ankara, Turkey. petek@hacettepe.edu.tr.ORCID http://orcid.org/0000-0002-7553-3915
Hacettepe University · TRAtilim University · TRGazi University · TRMiddle East Technical University · TR

Funding

Hacettepe University Scientific Research Project Coordination Unit TBB-2017-13-312
6 · The paper itself

Abstract

Metabolic diseases or injuries damage bone structure and self-renewal capacity. Trace elements and hydroxyapatite crystals are important in the development of biomaterials to support the renewal of bone extracellular matrix. In this study, it was assumed that the boron-loaded nanometer-sized hydroxyapatite composite supports the construction of extracellular matrix by controlled boron release in order to prevent its toxic effect. In this context, boron release from nanometer-sized hydroxyapatite was calculated by ICP-MS as in large proportion within 1 h and continuing release was provided at a constant low dose. The effect of the boron-containing nanometer-sized hydroxyapatite composite on the proliferation of SaOS-2 osteoblasts and human bone marrow-derived mesenchymal stem cells was evaluated by WST-1 and compared with the effects of nano-hydroxyapatite and boric acid. Boron increased proliferation of mesenchymal stem cells at high doses and exhibited different effects on osteoblastic cell proliferation. Boron-containing nano-hydroxyapatite composites increased osteogenic differentiation of mesenchymal stem cells by increasing alkaline phosphatase activity, when compared to nano-hydroxyapatite composite and boric acid. The molecular mechanism of effective dose of boron-containing hydroxyapatite has been assessed by transcriptomic analysis and shown to affect genes involved in Wnt, TGF-β, and response to stress signaling pathways when compared to nano-hydroxyapatite composite and boric acid. Finally, a safe osteoconductive dose range of boron-containing nano-hydroxyapatite composites for local repair of bone injuries and the molecular effect profile in the effective dose should be determined by further studies to validation of the regenerative therapeutic effect window.

Indexed as

Alkaline PhosphataseBiocompatible MaterialsBone RegenerationBoronCell DifferentiationCell Line, TumorCell ProliferationCells, CulturedDrug LiberationDurapatiteHumansMesenchymal Stem CellsNanocompositesOsteoblastsAlkaline PhosphataseBiocompatible MaterialsBoronDurapatiteBoneBoronMesenchymal stem cellNano-hydroxyapatiteSaOS-2Transcriptome

Identifiers

PMID31069715
OpenAlexW2944468693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.